Racial differences in oncogene mutations detected in early-stage low-grade endometrial cancers.

作者: Michele L. Cote , Govindaraja Atikukke , Julie J. Ruterbusch , Sara H. Olson , Shawnita Sealy-Jefferson

DOI: 10.1097/IGC.0B013E31826B1110

关键词:

摘要: Objective To describe the pattern and frequency of oncogene mutations in white African American women with endometrial cancer to determine if racial differences exist among pathologically similar tumors. Methods Patients from a large urban hospital were identified through medical records, representative formalin-fixed paraffin-embedded tumor blocks retrieved. The study sample included 150 patients (84 Americans) who underwent total abdominal hysterectomy for cancer. Sequenom MassARRAY system OncoCarta Assay version 1.0 (Sequenom) used test 238 19 common oncogenes. χ2 Fisher exact assess distribution variables by race mutation status. Results There 20 2 oncogenes (PIK3CA KRAS) tumors (12.7%). Most found PIK3CA (16/20). Thirteen percent endometrioid harbored (11 as did 29% malignant mixed Mullerian (3 1 KRAS). no observed serous, clear cell, or mucinous types. Among low-grade cancers, significantly associated harboring either KRAS (P = 0.04), 7 all 4 women. Conclusions This provides preliminary evidence that some subtypes histologically carcinoma differ race. Additional studies are needed further explore this phenomenon carcinoma.

参考文章(21)
C. M. Johnston, T. S. Frank, R. F. Caduff, Mutations of the Ki-ras oncogene in carcinoma of the endometrium. American Journal of Pathology. ,vol. 146, pp. 182- 188 ,(1995)
Marisa Pearce, Amy Cullinan, Grant Hogg, Dana Hosseini, Mathias Ehrich, Mutation profiling in tumor samples using the Sequenom OncoCarta|[trade]| Panel Nature Methods. ,vol. 6, ,(2009) , 10.1038/NMETH.F.254
Farhad Alexander-Sefre, Helga B. Salvesen, Andy Ryan, Naveena Singh, Lars A. Akslen, Nicolla MacDonald, George Wilbanks, Ian J. Jacobs, Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis. Gynecologic Oncology. ,vol. 91, pp. 218- 225 ,(2003) , 10.1016/S0090-8258(03)00505-5
M. Gymnopoulos, M.-A. Elsliger, P. K. Vogt, Rare cancer-specific mutations in PIK3CA show gain of function Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 5569- 5574 ,(2007) , 10.1073/PNAS.0701005104
Kiyoshi Ito, Keiko Watanabe, Suhail Nasim, Hironobu Sasano, Shinji Sato, Akira Yajima, Steven G. Silverberg, Carleton T. Garrett, K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient. Gynecologic Oncology. ,vol. 63, pp. 238- 246 ,(1996) , 10.1006/GYNO.1996.0313
Lluis Catasus, Alberto Gallardo, Miriam Cuatrecasas, Jaime Prat, PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters Modern Pathology. ,vol. 21, pp. 131- 139 ,(2008) , 10.1038/MODPATHOL.3800992
Andrew Berchuck, Gene P. Siegal, Masakuni Furusato, Yoshiteru Terashima, Matthew F. Kohler, Hiroshi Nishii, Hiroyuki Takahashi, Akio Tada, Sheryl L. Parker, Jeff Boyd, Hiroshi Sasaki, Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Research. ,vol. 53, pp. 1906- 1910 ,(1993)
Peter B Bach, Deborah Schrag, Otis W Brawley, Aaron Galaznik, Sofia Yakren, Colin B Begg, Survival of blacks and whites after a cancer diagnosis. JAMA. ,vol. 287, pp. 2106- 2113 ,(2002) , 10.1001/JAMA.287.16.2106
G. Larry Maxwell, Chunqiao Tian, John Risinger, Carol L. Brown, G. Scott Rose, J. Tate Thigpen, Gini F. Fleming, Holly H. Gallion, Wendy R. Brewster, Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma Cancer. ,vol. 107, pp. 2197- 2205 ,(2006) , 10.1002/CNCR.22232